Trestle Biotherapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Investors
-
14
Trestle Biotherapeutics General Information
Description
Developer of bioengineered therapies designed to address kidney diseases. The company creates functional therapeutic tissue by integrating stem cell biology and bio-fabrication, enabling healthcare providers to reduce reliance on dialysis and deliver improved treatment options for patients with chronic kidney disease.
Contact Information
Website
www.trestlebio.comCorporate Office
- 9276 Scranton Road
- San Diego, CA 92121
- United States
Corporate Office
- 9276 Scranton Road
- San Diego, CA 92121
- United States
Trestle Biotherapeutics Timeline
Trestle Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Early Stage VC | 20-Sep-2024 | Completed | Startup | |||
| 7. Accelerator/Incubator | 12-Jun-2023 | Completed | Startup | |||
| 6. Early Stage VC | 01-Mar-2022 | Completed | Startup | |||
| 5. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 4. Early Stage VC | 01-Dec-2021 | Completed | Startup | |||
| 3. Seed Round | 01-Apr-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 25-Mar-2021 | $125K | $125K | Completed | Startup | |
| 1. University Spin-Out | 11-Mar-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Trestle Biotherapeutics Patents
Trestle Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12781189-B2 | Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof | Active | 03-Oct-2024 | ||
| US-20260098246-A1 | Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof | Active | 03-Oct-2024 | ||
| WO-2026076399-A2 | Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof | Pending | 03-Oct-2024 | ||
| WO-2026076399-A3 | Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof | Pending | 03-Oct-2024 | ||
| WO-2026076410-A1 | Compositions and processes for vascularization of kidney tissues and in-vitro compositions thereof | Pending | 03-Oct-2024 | A61L27/3834 |
Trestle Biotherapeutics Signals
Trestle Biotherapeutics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| KidneyX | Accelerator/Incubator | |||
| Axial (San Francisco) | Venture Capital | Minority | ||
| C3 Ventures (VC) | Venture Capital | Minority | ||
| Draper Associates | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Trestle Biotherapeutics FAQs
-
When was Trestle Biotherapeutics founded?
Trestle Biotherapeutics was founded in 2020.
-
Where is Trestle Biotherapeutics headquartered?
Trestle Biotherapeutics is headquartered in San Diego, CA.
-
What is the size of Trestle Biotherapeutics?
Trestle Biotherapeutics has 6 total employees.
-
What industry is Trestle Biotherapeutics in?
Trestle Biotherapeutics’s primary industry is Biotechnology.
-
Is Trestle Biotherapeutics a private or public company?
Trestle Biotherapeutics is a Private company.
-
What is Trestle Biotherapeutics’s current revenue?
The current revenue for Trestle Biotherapeutics is .
-
How much funding has Trestle Biotherapeutics raised over time?
Trestle Biotherapeutics has raised $1.12M.
-
Who are Trestle Biotherapeutics’s investors?
KidneyX, Axial (San Francisco), C3 Ventures (VC), Draper Associates, and are 5 of 14 investors who have invested in Trestle Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process